These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12407649)

  • 1. Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution.
    MacGinley R; Cooney K; Alexander G; Cohen S; Goldsmith DJ
    Am J Kidney Dis; 2002 Nov; 40(5):1030-5. PubMed ID: 12407649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of relapsing sterile icodextrin-associated peritonitis on peritoneal dialysis outcome.
    Basile C; De Padova F; Montanaro A; Giordano R
    J Nephrol; 2003; 16(3):384-6. PubMed ID: 12832738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe peritoneal mononucleosis associated with icodextrin use in continuous ambulatory peritoneal dialysis.
    Martín J; Sansone G; Cirugeda A; Sánchez-Tomero JA; Muñoz C; Selgas R
    Adv Perit Dial; 2003; 19():191-4. PubMed ID: 14763060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culture-negative peritonitis associated with the use of icodextrin-containing dialysate in twelve patients treated with peritoneal dialysis.
    Boer WH; Vos PF; Fieren MW
    Perit Dial Int; 2003; 23(1):33-8. PubMed ID: 12691504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icodextrin-induced peritonitis: study of five cases and comparison with bacterial peritonitis.
    Touré F; Lavaud S; Mohajer M; Lavaud F; Canivet E; Nguyen P; Chanard J; Rieu P
    Kidney Int; 2004 Feb; 65(2):654-60. PubMed ID: 14717938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Icodextrine peritoneal dialysis solution in clinical practice].
    Opatrná S
    Vnitr Lek; 2008 Dec; 54(12):1155-60. PubMed ID: 19140524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.
    Wolfson M; Piraino B; Hamburger RJ; Morton AR;
    Am J Kidney Dis; 2002 Nov; 40(5):1055-65. PubMed ID: 12407652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sterile peritonitis after administration of icodextrin].
    Ekart R; Pecovnik-Balon B; Dvorsak B; Hojs R
    Acta Med Croatica; 2002; 56(4-5):185-7. PubMed ID: 12768899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.
    Parikova A; Zweers MM; Struijk DG; Krediet RT
    Adv Perit Dial; 2003; 19():186-90. PubMed ID: 14763059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sterile peritonitis associated with the use of icodextrin solution. Case report].
    Olszowska A; Zelichowski G; Pietrzak B
    Pol Merkur Lekarski; 2002 Nov; 13(77):406-7. PubMed ID: 12621760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific characteristics of peritoneal leucocyte populations during sterile peritonitis associated with icodextrin CAPD fluids.
    Glorieux G; Lameire N; Van Biesen W; Dequidt C; Vanholder R
    Nephrol Dial Transplant; 2003 Aug; 18(8):1648-53. PubMed ID: 12897108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Icodextrin in peritoneal dialysis therapy].
    Grzegorzewska AE; Antczak-Jedrzejczak D
    Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Icodextrin: What arguments for and against its use as an osmotic agent in peritoneal dialysis].
    Savenkoff B; Flechon-Meibody F; Goffin É
    Nephrol Ther; 2018 Jun; 14(4):201-206. PubMed ID: 29291942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent sterile peritonitis at onset of treatment with icodextrin solution.
    Pinerolo MC; Porri MT; D'Amico G
    Perit Dial Int; 1999; 19(5):491-2. PubMed ID: 11379866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icodextrin and intraperitoneal inflammation.
    Moriishi M; Kawanishi H
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis.
    Chow KM; Szeto CC; Kwan BC; Pang WF; Ma T; Leung CB; Law MC; Li PK
    Nephrol Dial Transplant; 2014 Jul; 29(7):1438-43. PubMed ID: 24578470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of fill volume on ultrafiltration with icodextrin in children on chronic peritoneal dialysis.
    Rousso S; Banh TM; Ackerman S; Piva E; Licht C; Harvey EA
    Pediatr Nephrol; 2016 Oct; 31(10):1673-9. PubMed ID: 27178072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.